default author photo

Yazdan Yazdanpanah

Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department

France

SCHOLARLY PAPERS

5

DOWNLOADS

812

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older People

Number of pages: 19 Posted: 17 Feb 2022
University of Lille - Laboratoire de Virologie ULR3610, CHU Lille - - Institute for Translational Research in Inflammation Inserm Univ. Lille, Université de Lille - Pôle de Gériatrie, Hôpital gériatrique Les Bateliers, CHU Lille - Department of Biostatistics, Université Lille - Clinical Microbiology Unit, Institut Pasteur de Lille, CHU Lille - - Institute for Translational Research in Inflammation Inserm Univ. Lille, CHU Lille - - Institute for Translational Research in Inflammation Inserm Univ. Lille, CHU Lille - Médecine et santé–travail, CHU Lille - Département de Maladies Infectieuses, CHU Lille - - Institute for Translational Research in Inflammation Inserm Univ. Lille, Université de Lille - Pôle de Gériatrie, Hôpital gériatrique Les Bateliers, Université de Lille - Pôle de Gériatrie, Hôpital gériatrique Les Bateliers, Université de Lille - Pôle de Gériatrie, Hôpital gériatrique Les Bateliers, CHU Lille - Département de Maladies Infectieuses, University of Lille - Clinical Investigation Center, University of Lille - Laboratoire de Virologie ULR3610, Université Lille - CHU Lille, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, Lille, Hauts-de-France, University of Lille - Médecine et santé-travail, University of Lille - Laboratoire de Virologie ULR3610, University of Lille - Centre de Ressources Biologiques, Université de Lille - Pôle de Gériatrie, Hôpital gériatrique Les Bateliers, Sorbonne University - UMR-S Inserm/UPMC 1135, CIMI-Paris (Centre de Recherches Immunité Maladies Infectieuses), Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, CHU Lille - - Institute for Translational Research in Inflammation Inserm Univ. Lille and CHU Lille - - Institute for Translational Research in Inflammation Inserm Univ. Lille
Downloads 298 (253,981)

Abstract:

Loading...

BNT162b2 vaccine, boost, SARS-CoV-2, Delta, Omicron, older people, immunogenicity

2.

Effects of Remdesivir in Hospitalized Patients with COVID-19: Systematic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials

Number of pages: 32 Posted: 11 Oct 2022
Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, Hôpital Bichat, APHP, University of Oslo - Oslo University Hospital, University of Paris, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Hôpital Bichat, APHP, University of British Columbia (UBC), University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Government of the People's Republic of China - Department of Pulmonary and Critical Care Medicine, Helsinki University Hospital, Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, Université Libre de Bruxelles (ULB), University of Claude Bernard Lyon 1, Hospices Civils de Lyon - Laboratoire de Virologie, University of Toronto, McGill University - Division of Experimental Medicine, University of Toronto - Sunnybrook Health Sciences Centre, University of Oslo - Oslo University Hospital, University of Oslo - Department of Immunology and Transfusion Medicine, University of Oslo - Oslo University Hospital, affiliation not provided to SSRN, China-Japan Friendship Hospital - Department of Pulmonary and Critical Care Medicine, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - Basel Institute for Clinical Epidemiology and Biostatistics, University of Basel - University Hospital Basel, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Oslo - Oslo University Hospital and University of Basel - University Hospital Basel
Downloads 191 (399,431)

Abstract:

Loading...

Remdesivir, COVID-19, systematic review, individual patient data meta analysis, randomized controlled trials, GS-5734

3.

Effects of Jak Inhibitors in Adults Hospitalized Due to Covid-19: A Systematic Review and Individual Participant Data Meta-Analysis of Randomized Clinical Trials

Number of pages: 27 Posted: 03 Oct 2024
Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, University of Basel, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University Hospitals of Geneva, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), The Emmes Company, Hospital Universitario de Fuenlabrada, Hospital Universitario de Fuenlabrada, Ospedali Riuniti di Ancona, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Mazandaran University of Medical Sciences, University of Cambridge, NHS Foundation Trust - Cambridge University Hospitals, Hospital Universitario La Paz, Hospital Universitario La Paz, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Hospital Israelita Albert Einstein, Hospital Israelita Albert Einstein, University of Sydney - George Institute for Global Health, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, Norwegian Institute of Public Health, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Université Libre de Bruxelles (ULB) - Department of Infectious Disease, Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, Hôpital Bichat, APHP, Université Paris Cité, Université Paris Cité, Université Paris Cité, University of Nantes - INSERM, Sorbonne University, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Section for Clinical Immunology and Infectious Diseases and University of Basel - University Hospital Basel
Downloads 174 (437,795)

Abstract:

Loading...

4.

Safety of Baricitinib in Vaccinated Patients with Severe and Critical COVID-19. Sub Study of the Randomised Bari-SolidAct Trial

Number of pages: 30 Posted: 19 Jul 2024
University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, Lyon Sud Hospital, University of Lille, Hospital Universitario La Paz, Hospices Civils de Lyon, University of Claude Bernard Lyon 1, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Nantes - INSERM, University of Nantes - INSERM, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Department of Immunology and Transfusion Medicine, University of Oslo - Institute of Clinical Medicine, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Amiens Picardie University Hospital - Intensive Care Unit, Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - CHU de Bordeaux, Assistance Publique-Hôpitaux de Paris - Service de Réanimation Médicale Et Infectieuse (MI2), Université Paris Cité, Louis Mourier Hospital, Dijon University Hospital - Clinical Epidemiology Unit, University of Nantes - INSERM, Centro Hospitalar Universitário de Lisboa Central, University of Oslo, Vestre Viken Hospital Trust, Vestre Viken Hospital Trust, University of Stavanger - Stavanger University Hospital, University of Oslo - Oslo University Hospital, University Hospital North Norway, Østfold Hospital Kalnes - Department of Infectious Diseases, University of Oslo - Oslo University Hospital, University of Oslo - Institute of Clinical Medicine, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, University of Oslo - Oslo University Hospital, University of Oslo - Division of Emergencies and Critical Care, University of Oslo - Oslo University Hospital, University of Oslo - Institute of Clinical Medicine and University of Oslo - Section for Clinical Immunology and Infectious Diseases
Downloads 94 (720,278)

Abstract:

Loading...

COVID-19, vaccination, baricitinib, JAK inhibitors, immunomodulation, elderly

5.

Epidemiological, Economic and Budgetary Effects of Expanding the Screening for Hepatitis C Virus in Brazil: A Modeling Study

Number of pages: 32 Posted: 06 Aug 2025
University of Paris, University of Paris, University of Paris, University of Paris, University of Paris, University of Paris, Base Hospital of the Federal District, Fundação Oswaldo Cruz, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, Government of Bhutan - Ministry of Finance and University of Paris
Downloads 55 (1,010,164)

Abstract:

Loading...

Budget Impact Analysis, Cost-Effectiveness Analysis, Decision Analysis, Direct Acting Antivirals, Hepatitis C, Mathematical Modeling, Universal Screening